Your browser doesn't support javascript.
loading
In sickness and health - a questionnaire based study regarding immune mediated diseases and neoplasia in Swedish Nova Scotia Duck Tolling Retrievers.
Nilsson, Malin; Kozyrev, Sergey V; Lindblad-Toh, Kerstin; Rönnberg, Henrik; Hansson-Hamlin, Helene.
Afiliación
  • Nilsson M; Department of Clinical Sciences, Swedish University of Agricultural Sciences, Uppsala, Sweden. malin.nilsson@slu.se.
  • Kozyrev SV; Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
  • Lindblad-Toh K; SciLifeLab, Uppsala University, Uppsala, Sweden.
  • Rönnberg H; Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala, Sweden.
  • Hansson-Hamlin H; SciLifeLab, Uppsala University, Uppsala, Sweden.
Acta Vet Scand ; 66(1): 39, 2024 Aug 15.
Article en En | MEDLINE | ID: mdl-39148122
ABSTRACT

BACKGROUND:

The Nova Scotia Duck Tolling Retriever (NSDTR) has previously been highlighted as a breed at risk for developing immune mediated diseases and cancer. The immune response is of great importance for the development of neoplastic disease and a dysregulated immune response may predispose to cancer. Two of the commonly seen immune mediated diseases in NSDTRs are immune mediated rheumatic disease (IMRD), which bears similarities to systemic lupus erythematosus (SLE) affecting humans, and steroid-responsive meningitis-arteritis (SRMA), which is a non-infectious inflammation of the meninges and the leptomeningeal vessels. The aim of this survey study was to investigate the lifetime prevalence of immune mediated diseases and tumors among Swedish NSDTRs based on owners' information. The study design was cross-sectional. A questionnaire was sent to 4102 persons who owned or had previously owned a NSDTR. The questions concerned information about the dog and its overall health status as well as specific diseases.

RESULTS:

The response rate was 30%, including 935 live NSDTRs, corresponding to approximately 20% of the current population registered in Sweden (n = 4564), and 177 dead dogs. The surveyed dogs were spread over different ages and sex and corresponded to the typical demographic profile of the general dog population. Of the 935 individuals that were alive, 28 dogs (3%) were reported as previously diagnosed with IMRD and 33 dogs (3.5%) were reported as previously diagnosed with SRMA, one dog was reported to have been diagnosed with both SRMA and IMRD. There were 129 dogs (14%) reported to have or have had a neoplasia of some kind. For the dead dogs (n = 177), almost 40% of the owners reported neoplasia as the main reason for death/euthanasia.

CONCLUSION:

This study reports an estimated lifetime prevalence of IMRD and SRMA, in the studied population of Swedish NSDTRs, of 3.0 and 3.5% respectively. In this study, 14% of the living dogs (n = 935) were reported to have a neoplasia of some kind and almost 40% of the deceased dogs (n = 177) were euthanized due to neoplasia or suspicion of it.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Enfermedades de los Perros / Neoplasias País/Región como asunto: Europa Idioma: En Revista: Acta Vet Scand Año: 2024 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Enfermedades de los Perros / Neoplasias País/Región como asunto: Europa Idioma: En Revista: Acta Vet Scand Año: 2024 Tipo del documento: Article